Study title: The use of CY216 (fraxiparine) in Paediatric haemodialysis Fraxiparine : premier symposium international; 01 Nov 1987-01 Nov 1987; Paris, France. 2005. 19-19.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Hemic and Lymphatic Diseases | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NADROPARIN | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |